| Univariate | Multivariate (stepwise) | ||||
---|---|---|---|---|---|---|
HR | 95.0% CI | P | HR | 95.0% CI | P | |
Age < 40 vs >40Y | 1.67 | 0.63–4.39 | 0.302 |  |  |  |
Sex M vs F | 1.05 | 0.37–2.99 | 0.924 |  |  |  |
Histopathologicalsubtype | 1.14 | 0.26–5.01 | 0.857 |  |  |  |
USP22, low vs. high | 6.54 | 1.49–28.79 | 0.013 | 5.25 | 1.15–23.93 | 0.032 |
SIRT1, low vs. high | 3.48 | 1.22–9.92 | 0.02 |  |  |  |
Ecadherin, low vs. high | 0.29 | 0.08–1 | 0.05 |  |  |  |
LN involvement | 3.31 | 1.22–9.01 | 0.019 |  |  |  |
Vascular invasion | 3.69 | 1.06–12.9 | 0.041 |  |  |  |
Capsular invasion | 4.03 | 1.52–10.67 | 0.005 |  |  |  |
Extra-thyroid extension | 2.23 | 0.86–5.81 | 0.1 |  |  |  |
LN involvement | 2.63 | 1.01–6.86 | 0.049 |  |  |  |
Stage | 2.92 | 1.51–5.63 | 0.001 |  |  |  |
Distant metastasis | 4.66 | 1.56–13.9 | 0.006 | 3.06 | 1.01–9.29 | 0.048 |
Surgery | 1.14 | 0.65–2 | 0.641 |  |  |  |
Tumor size | 3.21 | 1.17–8.78 | 0.023 |  |  |  |